Atlas Trials

A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer

Clinical trial NCT01717898 · TERMINATED

Trial details

NCT number
NCT01717898
Sponsor
Charles Ryan
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Castrate-resistant Prostate Cancer
Start date
2013-01-31
Primary completion
2013-09-03
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.